Nine Diagnostics was selected to present at the 2025 MIT Health Science Forum, hosted by the MIT Industrial Liaison Program (ILP) and MIT Startup Exchange. Held on May 8, 2025, the forum convened MIT researchers, global industry leaders, and select startups to showcase cutting-edge developments at the intersection of science, technology, and health.
The event focused on five key areas shaping the future of healthcare:
AI for biomolecular modeling
Biomanufacturing for cell and gene therapies
Drug delivery
Precision oncology
Advanced diagnostics
Nine Diagnostics presented its AI-powered nanosensor platform, which enables real-time insights into disease biology using small-volume patient samples. The technology supports both early detection and treatment monitoring by integrating multidimensional data—including molecular signals, patient demographics, and clinical context—into a unified decision support framework.
The forum provided an opportunity for thought leaders and startups to engage in cross-sector dialogue, explore translational partnerships, and accelerate innovation across biomedical domains. Being selected to present reflects Nine Diagnostics’ leadership in advancing precision diagnostics and its alignment with MIT’s mission to drive impactful healthcare innovation.
Learn more about the event here: MIT ILP Health Science Forum 2025
